drugset / Trial / NCT06560892

Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine

NCT06560892 ↗

RandomizedParallel-groupOpen-labelOther

Summary

For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was performed with the objective of comparing the mean duration of analgesia of intraperitoneal bupivacaine with dexmedetomidine to intraperitoneal bupivacaine alone in patients undergoing laparoscopic cholecystectomy.

Timeline

Start
2024-01-01
Primary completion
2024-06-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other
Background Bupivacaine Other / unclassified 0.25 % Other
Background Bupivacaine Other / unclassified 50 ml Other

Indications